(Q71466248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

title

Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

Marco Salvatore

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

author name string

E Cascone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

F Arlotta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

G Vitale

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

L Celentano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

G Lombardi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

language of work or name

English

0 references

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

1114-1118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8780551%20AND%20SRC:MED&resulttype=core&format=json

Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Human γ-Lipotropin Radioimmunoassay: Identification of Immunoreactive γ-Lipotropin in Human Plasma and Tissue*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Potential indications for octreotide in endocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Evaluation of receptors for somatostatin in various tumors using different analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Surgical management and follow-up of medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Medullary thyroid carcinoma: prognostic factors and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion: a new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Response of medullary thyroid cancer to low-dose alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Clinical effects of interferon therapy with special emphasis on antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

Antitumor effects of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960901%2978%3A5%3C1114%3A%3AAID-CNCR23%3E3.0.CO%3B2-4

10.1002/(SICI)1097-0142(19960901)78:5<1114::AID-CNCR23>3.0.CO;2-4

21 January 2018

Identifiers

DOI

0 references

1 reference